Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Amit Munshi files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- AI Biotechnology LLC - $12.50M in ZURA purchases and sales in the last 12 months
- Todd Watanabe - $4.44M in ARQT purchases and sales in the last 12 months
- Sands Capital Life Sciences Pulse Fund II, L.P. - $3.00M in IKT purchases and sales in the last 12 months
- Masaru Matsuda - $2.21M in ARQT purchases and sales in the last 12 months
- Howard G. Welgus - $1.95M in ARQT purchases and sales in the last 12 months
- Patrick Burnett - $1.56M in ARQT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Amit Munshi?
Amit Munshi is a corporate insider of Inhibikase Therapeutics, Inc. (IKT). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Amit Munshi last file a Form 4?
The most recent primary Form 4 on record is dated 30 June 2026, one of 8 filings going back to 2024.
Has Amit Munshi been buying or selling stock?
Recorded transactions: 1 open-market purchase ($500K) and 0 open-market sales across all tracked filings.
